{"gene":"ECSIT","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1999,"finding":"ECSIT acts as an adaptor protein bridging TRAF6 to MEKK-1 in the Toll/IL-1 signaling pathway; wild-type ECSIT accelerates MEKK-1 processing while a dominant-negative fragment blocks MEKK-1 processing and NF-κB activation.","method":"Yeast two-hybrid, co-immunoprecipitation, dominant-negative overexpression, NF-κB reporter assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction studies plus functional dominant-negative experiments; foundational paper replicated and built upon by multiple subsequent labs","pmids":["10465784"],"is_preprint":false},{"year":2003,"finding":"ECSIT is required for BMP signaling during mouse embryogenesis; it associates constitutively with Smad4 and associates with Smad1 in a BMP-inducible manner, and together with Smad1/Smad4 binds promoters of specific BMP target genes. Ecsit null mice show impaired mesoderm formation and embryonic lethality at E7.5.","method":"Targeted gene knockout (null mutation), co-immunoprecipitation, chromatin immunoprecipitation, shRNA knockdown, reporter assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo knockout with defined phenotype, reciprocal Co-IP, ChIP, and functional rescue experiments in single rigorous study","pmids":["14633973"],"is_preprint":false},{"year":2007,"finding":"ECSIT localizes to mitochondria via an N-terminal targeting signal, where it interacts with the assembly chaperone NDUFAF1 in 500–850 kDa complexes; RNAi knockdown of either ECSIT or NDUFAF1 severely impairs mitochondrial complex I assembly and function.","method":"Affinity purification, subcellular fractionation, RNAi knockdown, blue native PAGE, mitochondrial function assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal affinity purification, bidirectional RNAi, biochemical fractionation demonstrating mitochondrial localization with functional consequence; replicated in multiple subsequent studies","pmids":["17344420"],"is_preprint":false},{"year":2012,"finding":"TRIM59 interacts with ECSIT (co-immunoprecipitation) and acts as a negative regulator of NF-κB and IRF-3/7-mediated signaling; overexpression of TRIM59 represses NF-κB, IFN-β promoter, and ISRE transcriptional activities, while TRIM59 knockdown enhances them. TRIM59 also inhibits phosphorylation and dimerization of IRF3 and IRF7.","method":"Co-immunoprecipitation, luciferase reporter assays, siRNA knockdown, Western blot (phosphorylation)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single Co-IP plus functional reporter assays and phosphorylation analysis; single lab","pmids":["22588174"],"is_preprint":false},{"year":2014,"finding":"Upon LPS stimulation, ECSIT forms a trimeric complex with TAK1 and TRAF6; ECSIT interacts with each protein and regulates TAK1 activity to activate NF-κB. ECSIT mutants lacking the TAK1- or TRAF6-interacting domain cannot restore NF-κB activity or cytokine production in ECSIT-knockdown cells.","method":"Co-immunoprecipitation of endogenous proteins, ECSIT-knockdown (THP-1), domain-deletion mutant rescue, NF-κB reporter assay, cytokine ELISA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — endogenous complex IP, domain-mapping mutagenesis, knockdown rescue, and multiple functional readouts; single lab with orthogonal methods","pmids":["25371197"],"is_preprint":false},{"year":2014,"finding":"ECSIT ubiquitination at lysine 372 is required for its interaction with p65/p50 NF-κB proteins and their nuclear co-localization following TLR4 stimulation; the K372A mutant fails to interact with NF-κB subunits and cannot restore NF-κB DNA-binding activity or cytokine production in ECSIT-knockdown cells.","method":"Co-immunoprecipitation, site-directed mutagenesis (K372A), subcellular fractionation, NF-κB EMSA/reporter assays, cytokine measurement, ECSIT-knockdown rescue","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — active-site (ubiquitination site) mutagenesis with functional validation, knockdown rescue, multiple orthogonal assays; single lab","pmids":["25355951"],"is_preprint":false},{"year":2014,"finding":"ECSIT serves as an essential scaffolding protein that bridges RIG-I and MDA5 to VISA (MAVS) on mitochondria, mediating virus-triggered type I IFN induction; ECSIT overexpression potentiates IRF3 activation and IFNB1 expression, while ECSIT knockdown impairs these antiviral responses.","method":"Co-immunoprecipitation, siRNA knockdown, overexpression, IRF3 activation assay, IFNB1 reporter/expression assay","journal":"Journal of innate immunity","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP of ECSIT with VISA/RIG-I/MDA5, bidirectional functional perturbation (OE and KD); single lab","pmids":["25228397"],"is_preprint":false},{"year":2014,"finding":"Hepatitis B virus X protein (HBx) physically interacts with ECSIT (GST pulldown and co-IP); the interacting region of HBx maps to amino acids 51–80; the HBx–ECSIT interaction augments IL-1β-induced NF-κB activation by increasing IKK and IκBα phosphorylation and promoting p65/p50 nuclear translocation.","method":"GST pulldown, co-immunoprecipitation, CytoTrap two-hybrid, deletion analysis, NF-κB reporter assay, Western blot (phosphorylation)","journal":"Virus research","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — GST pulldown plus co-IP with domain mapping and functional signaling assays; single lab","pmids":["25449573"],"is_preprint":false},{"year":2017,"finding":"Peroxiredoxin-6 (Prdx6) competitively interacts with ECSIT at the TRAF-C domain of TRAF6, disrupting the TRAF6–ECSIT complex; this inhibits ECSIT ubiquitination, reduces mitochondrial ROS production, and suppresses TLR4-induced NF-κB activation and bactericidal activity.","method":"Co-immunoprecipitation, Prdx6 knockdown, competitive binding assay, mitochondrial ROS measurement, NF-κB reporter, cytokine assay, bacterial survival assay","journal":"Frontiers in cellular and infection microbiology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — competitive Co-IP with domain mapping, bidirectional perturbation (OE and KD), multiple functional readouts; single lab","pmids":["28393051"],"is_preprint":false},{"year":2018,"finding":"Conditional knockout of ECSIT in macrophages completely disrupts complex I activity and the CI holoenzyme, causes a metabolic shift to glycolysis, increases constitutive mitochondrial ROS, and impairs mitophagy. ECSIT associates with the mitophagy regulator PINK1 and undergoes Parkin-dependent ubiquitination; ECSIT deletion increases mitochondrial Parkin without restoring mitophagy.","method":"Conditional knockout mouse (Cre-lox), complex I activity assay, blue native PAGE, metabolic flux (Seahorse), mROS measurement, co-immunoprecipitation (PINK1), ubiquitination assay","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with detailed mechanistic dissection, multiple orthogonal assays (biochemical, metabolic, mitophagy), Co-IP of PINK1 interaction; single lab but highly rigorous","pmids":["29514094"],"is_preprint":false},{"year":2018,"finding":"The ECSIT V140A mutation increases ECSIT affinity for the S100A8/S100A9 heterodimer, potentiating NF-κB activation and NADPH oxidase activity. ECSIT-T419C knock-in mice showed higher peritoneal NADPH oxidase activity than wild-type in response to LPS. ECSIT-V140A-expressing ENKTL cells produced TNF-α and IFN-γ that induced macrophage activation and cytokine secretion.","method":"Exome sequencing, knock-in mouse model, co-immunoprecipitation, NADPH oxidase activity assay, NF-κB reporter, cytokine measurement, xenograft model","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — knock-in mouse, biochemical interaction studies, functional assays in cells and in vivo; single lab but multiple orthogonal methods","pmids":["29291352"],"is_preprint":false},{"year":2019,"finding":"CRBN (cereblon) translocates to mitochondria upon TLR4 stimulation and disrupts the ECSIT–TRAF6 complex, thereby inhibiting TRAF6-induced ubiquitination of ECSIT and suppressing mitochondrial ROS production and bactericidal activity.","method":"Co-immunoprecipitation, CRBN knockdown/knockout, mitochondrial fractionation, mROS measurement, bacterial survival assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP showing competitive disruption, bidirectional perturbation, functional mROS and bactericidal readouts; single lab","pmids":["31620128"],"is_preprint":false},{"year":2019,"finding":"p62 (SQSTM1) interacts with the internal domain of ECSIT, inhibits TRAF6–ECSIT association, and attenuates ECSIT ubiquitination, thereby suppressing TLR4-mediated NF-κB activation; p62-knockout MEF cells and mice show markedly enhanced TLR4 signaling and inflammatory responses.","method":"Co-immunoprecipitation, domain mapping, p62 knockout MEF cells, p62 knockout mice, NF-κB reporter, cytokine measurement, ubiquitination assay","journal":"Immune network","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP with domain mapping, p62-KO cells and mice with functional signaling readouts; single lab","pmids":["31281713"],"is_preprint":false},{"year":2021,"finding":"Human ECSIT (hECSIT) is highly labile compared to murine Ecsit; low hECSIT levels lead to reduced complex I assembly and activity, impaired oxidative phosphorylation, reduced ATP production, altered mitochondrial dynamics (reduced fusion, increased fission), and severe cardiac hypertrophy in humanized knock-in mice. ECSIT also has a cardiomyocyte-intrinsic role in mitochondrial function.","method":"Humanized knock-in mouse (mEcsit replaced by hECSIT), complex I activity/assembly assay, Seahorse metabolic flux, mitochondrial morphology imaging, cardiac function assays","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Moderate — transgenic knock-in mouse with multiple orthogonal biochemical, metabolic, and in vivo cardiac readouts; single lab but rigorous","pmids":["34032637"],"is_preprint":false},{"year":2023,"finding":"RANKL promotes ECSIT–TRAF6 interaction and increases mitochondrial ECSIT levels in osteoclast progenitors; ECSIT silencing decreases complex I activity, oxygen consumption, NAD+/NADH ratio, ATP production, and increases mitochondrial ROS, abrogating RANKL-driven stimulation of oxidative phosphorylation and osteoclastogenesis. 17β-estradiol (E2) abrogates these RANKL-induced effects on ECSIT.","method":"Co-immunoprecipitation, subcellular fractionation, shRNA knockdown, Seahorse XF metabolic analysis, complex I activity assay, ROS measurement, mitochondrial membrane potential assay","journal":"Frontiers in endocrinology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, fractionation, shRNA KD with multiple orthogonal metabolic and functional assays; single lab but comprehensive methodology","pmids":["37152948"],"is_preprint":false},{"year":2023,"finding":"ECSIT-N209I ENU-induced mutation causes tissue-specific complex I assembly defects specifically in cardiac tissue, leading to hypertrophic cardiomyopathy without affecting complex I in other tissues, demonstrating tissue-specific requirements for ECSIT in complex I assembly.","method":"ENU mutagenesis screen, Seahorse extracellular flux, biochemical complex I assays, blue native PAGE, cardiac phenotyping","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo point mutation with tissue-specific biochemical and functional validation; single lab","pmids":["37395010"],"is_preprint":false},{"year":2023,"finding":"Intestinal cell-specific ablation of ECSIT causes metabolic reprogramming toward amino acid-based metabolism, demethylation and upregulation of eIF4F pathway genes, and consequently enhanced YAP protein translation (not transcription), disrupting intestinal differentiation and promoting tumorigenesis.","method":"Intestinal epithelium-specific conditional knockout, proteomics, metabolomics, ribosome profiling/translation assays, Western blot, reporter assays","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific KO with multi-omics and mechanistic follow-up on translation pathway; single lab","pmids":["37409430"],"is_preprint":false},{"year":2024,"finding":"ECSIT mediates fumarate synthesis in CD8+ T cells; T cell-specific ECSIT ablation abolishes fumarate production and abrogates TCF-1 expression via KDM5-mediated demethylation of the TCF-1 promoter, impairing memory CD8+ T cell differentiation in a cell-intrinsic manner.","method":"T cell-specific conditional knockout, metabolomics (fumarate measurement), ChIP/methylation analysis, KDM5 inhibition, adoptive transfer experiments","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with metabolomics, epigenetic mechanism (ChIP, methylation), cell-intrinsic adoptive transfer; single lab but multiple orthogonal methods in rigorous study","pmids":["38326554"],"is_preprint":false},{"year":2025,"finding":"A novel 42-kDa ECSIT isoform encoded by transcript variant Ecsit-X4 localizes to mitochondria of adult cardiomyocytes; it interacts with STAT3 and increases mitochondrial STAT3 levels and serine 727 phosphorylation, thereby promoting mitochondrial bioenergetics and protecting against pressure overload-induced cardiac hypertrophy.","method":"AAV9-mediated gene therapy, cardiomyocyte-specific Ecsit conditional knockout, co-immunoprecipitation (STAT3 interaction), Western blot (phospho-STAT3-S727), mitochondrial fractionation, Seahorse metabolic analysis, TAC surgical model","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO rescue and AAV gene therapy with Co-IP and phosphorylation analysis; single lab but multiple in vivo and biochemical methods","pmids":["39746855"],"is_preprint":false},{"year":2025,"finding":"Mycobacterium tuberculosis virulence factor HBHA directly binds ECSIT, disrupts the ECSIT–TRAF6 complex, and inhibits ECSIT ubiquitination in macrophages, thereby suppressing autophagy (LC3-II conversion and Beclin-1 expression unchanged in ECSIT-knockdown cells upon HBHA treatment) and promoting intracellular mycobacterial survival.","method":"Co-immunoprecipitation, ECSIT knockdown (RAW264.7), ubiquitination assay, LC3-II/Beclin-1 Western blot, intracellular bacterial survival assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP, genetic ablation with mechanistic readouts (ubiquitination, autophagy markers, bacterial survival); single lab","pmids":["41209015"],"is_preprint":false},{"year":2026,"finding":"Mitochondria-targeted ECSIT overexpression promotes localization of deubiquitinase OTUD3 to mitochondria; OTUD3 then stabilizes SIRT3 via deubiquitination, inhibiting mtDNA oxidation and alleviating diet-induced MASH phenotypes.","method":"Mitochondria-targeted transgenic mice (ECSITMTG), co-immunoprecipitation, deubiquitination assay, mitochondrial fractionation, mtDNA oxidation measurement, dietary MASH models","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic mouse model with Co-IP, deubiquitination biochemistry, and functional metabolic readouts; single lab","pmids":["41640247"],"is_preprint":false}],"current_model":"ECSIT is a multifunctional adaptor protein that operates in at least three major mechanistic contexts: (1) in innate immune/TLR signaling, it bridges TRAF6 to MEKK-1 to promote NF-κB activation, forms a TAK1-ECSIT-TRAF6 trimeric complex, scaffolds RIG-I/MDA5 to MAVS for antiviral IFN induction, and its ubiquitination at K372 is required for NF-κB p65/p50 nuclear interaction; (2) in mitochondria (directed by an N-terminal targeting sequence), it interacts with NDUFAF1 and is essential for mitochondrial complex I assembly and activity, regulates mitochondrial ROS production that facilitates bacterial clearance, associates with PINK1 and undergoes Parkin-dependent ubiquitination to regulate mitophagy, and a cardiomyocyte-specific isoform (ECSIT-X4) interacts with STAT3 to sustain mitochondrial bioenergetics; and (3) in development and differentiation, it co-operates with Smad1/Smad4 as a BMP pathway co-factor for mesoderm formation, and in CD8+ T cells it mediates fumarate synthesis that suppresses KDM5-dependent TCF-1 promoter demethylation to support memory T cell development."},"narrative":{"mechanistic_narrative":"ECSIT is a multifunctional adaptor protein that couples innate immune signaling to mitochondrial function, operating both as a scaffold in Toll/IL-1 receptor pathways and as an essential factor for respiratory complex I assembly [PMID:10465784, PMID:17344420]. In TLR/IL-1 signaling it bridges TRAF6 to MEKK-1 to drive NF-κB activation [PMID:10465784], assembles a TAK1–ECSIT–TRAF6 trimeric complex through distinct interaction domains required for cytokine production [PMID:25371197], and scaffolds RIG-I and MDA5 onto MAVS to induce type I interferon during antiviral responses [PMID:25228397]. ECSIT ubiquitination at lysine 372 is required for its interaction with NF-κB p65/p50 and their nuclear function following TLR4 stimulation [PMID:25355951], and the integrity of the TRAF6–ECSIT complex — controlled by competitive binders including Prdx6, CRBN, p62/SQSTM1, and the pathogen factors HBx and HBHA — governs ECSIT ubiquitination, mitochondrial ROS production, and bactericidal/autophagic activity [PMID:28393051, PMID:31620128, PMID:31281713, PMID:41209015]. Independently, ECSIT localizes to mitochondria via an N-terminal targeting signal where it partners with the assembly chaperone NDUFAF1 and is indispensable for complex I assembly and oxidative phosphorylation [PMID:17344420, PMID:29514094]; loss of ECSIT collapses complex I, shifts metabolism toward glycolysis, raises constitutive mitochondrial ROS, and impairs mitophagy, with ECSIT associating with PINK1 and undergoing Parkin-dependent ubiquitination [PMID:29514094]. This mitochondrial role underlies tissue-specific physiology: human ECSIT lability or point mutations cause cardiac complex I deficiency and hypertrophy [PMID:34032637, PMID:37395010], a cardiomyocyte ECSIT-X4 isoform sustains bioenergetics through mitochondrial STAT3 [PMID:39746855], and ECSIT supports RANKL-driven osteoclast metabolism [PMID:37152948]. ECSIT also acts at the chromatin/metabolite interface, cooperating with Smad1/Smad4 as a BMP co-factor essential for mesoderm formation [PMID:14633973] and, in CD8+ T cells, driving fumarate synthesis that suppresses KDM5-dependent demethylation of the TCF-1 promoter to support memory differentiation [PMID:38326554].","teleology":[{"year":1999,"claim":"Established ECSIT's founding role as a signaling adaptor, answering how TRAF6 connects to downstream MAP3K activity in Toll/IL-1 signaling.","evidence":"Yeast two-hybrid, Co-IP, and dominant-negative NF-κB reporter assays identifying ECSIT as a TRAF6–MEKK-1 bridge","pmids":["10465784"],"confidence":"High","gaps":["Did not resolve whether MEKK-1 processing is direct or requires additional factors","No structural basis for the bridging interaction"]},{"year":2003,"claim":"Revealed an unexpected developmental function, showing ECSIT acts as a BMP/Smad transcriptional co-factor required for embryonic mesoderm formation.","evidence":"Ecsit-null mice (embryonic lethal E7.5), Smad1/Smad4 Co-IP, ChIP at BMP target promoters, shRNA and reporter assays","pmids":["14633973"],"confidence":"High","gaps":["Mechanistic link between ECSIT's TLR-adaptor and Smad co-factor roles unresolved","Direct DNA-binding vs. recruitment by Smads not distinguished"]},{"year":2007,"claim":"Identified a distinct mitochondrial function, answering where ECSIT localizes and revealing it is essential for respiratory complex I assembly.","evidence":"Affinity purification with NDUFAF1, subcellular fractionation, bidirectional RNAi, blue native PAGE","pmids":["17344420"],"confidence":"High","gaps":["How a single protein partitions between signaling and mitochondrial pools not defined","Biochemical role within the assembly intermediate not specified"]},{"year":2014,"claim":"Dissected the architecture and ubiquitination requirements of ECSIT in TLR signaling, establishing the trimeric TAK1–ECSIT–TRAF6 complex and a K372 ubiquitination switch for NF-κB engagement.","evidence":"Endogenous Co-IP, domain-deletion and K372A mutant rescue in knockdown cells, EMSA, cytokine readouts","pmids":["25371197","25355951"],"confidence":"High","gaps":["Identity of the K372 E3 ligase not established","Whether ubiquitination is mono- or poly- and its chain type undefined"]},{"year":2014,"claim":"Extended ECSIT's immune scaffolding to antiviral sensing and identified viral and host regulators, showing it bridges RIG-I/MDA5 to MAVS and is targeted by HBx and TRIM59.","evidence":"Co-IP, siRNA/overexpression IRF3 and IFNB1 assays; GST pulldown and reporter assays for HBx and TRIM59","pmids":["25228397","25449573","22588174"],"confidence":"Medium","gaps":["RIG-I/MDA5-MAVS bridging shown by Co-IP without reciprocal structural validation","Host vs. viral regulation hierarchy unresolved"]},{"year":2018,"claim":"Linked ECSIT's mitochondrial role to immune effector output and mitophagy, showing complex I loss reprograms metabolism, elevates ROS, and disrupts PINK1/Parkin-dependent mitophagy.","evidence":"Macrophage conditional knockout, complex I assays, Seahorse, PINK1 Co-IP, Parkin-dependent ubiquitination assay; ENKTL ECSIT-V140A knock-in mouse and S100A8/A9 binding","pmids":["29514094","29291352"],"confidence":"High","gaps":["How ECSIT integrates into mitophagy beyond PINK1 association not defined","Mechanism of V140A gain-of-function affinity change not structurally explained"]},{"year":2019,"claim":"Defined the TRAF6–ECSIT complex as a regulatory node, showing competitive binders (CRBN, p62) and the requirement of ECSIT ubiquitination for mitochondrial ROS and bactericidal activity.","evidence":"Co-IP/domain mapping, p62-KO cells and mice, CRBN knockdown, mROS and bacterial survival assays","pmids":["31620128","31281713","28393051"],"confidence":"Medium","gaps":["Whether competitive disruptors act at the same TRAF-C interface for all is not unified","Quantitative contribution of each regulator in vivo unclear"]},{"year":2021,"claim":"Demonstrated species- and tissue-specific physiological consequences of ECSIT abundance, with human ECSIT lability causing complex I deficiency and cardiac hypertrophy.","evidence":"Humanized hECSIT knock-in mice, complex I assembly/activity assays, Seahorse, mitochondrial morphology imaging, cardiac phenotyping","pmids":["34032637"],"confidence":"High","gaps":["Molecular basis of human ECSIT instability not defined","Cardiomyocyte-intrinsic vs. systemic contributions only partly separated"]},{"year":2023,"claim":"Generalized ECSIT's metabolic-gatekeeper role across osteoclasts, cardiac tissue, and intestine, including a translation-control mechanism affecting YAP.","evidence":"RANKL osteoclast Co-IP and Seahorse; ENU ECSIT-N209I cardiac mutant; intestinal conditional KO with proteomics, metabolomics, and ribosome profiling","pmids":["37152948","37395010","37409430"],"confidence":"High","gaps":["Mechanism linking complex I loss to eIF4F demethylation and YAP translation incompletely defined","Tissue specificity of complex I requirement mechanistically unexplained"]},{"year":2024,"claim":"Connected ECSIT-dependent mitochondrial metabolism to epigenetic control of cell fate, showing ECSIT-driven fumarate suppresses KDM5 demethylation of the TCF-1 promoter for memory CD8+ T cell formation.","evidence":"T cell-specific conditional KO, fumarate metabolomics, ChIP/methylation, KDM5 inhibition, adoptive transfer","pmids":["38326554"],"confidence":"High","gaps":["How ECSIT enzymatically/structurally controls fumarate flux not detailed","Generality of the fumarate-KDM5 axis to other cell types unknown"]},{"year":2025,"claim":"Identified an isoform-specific and STAT3-dependent cardioprotective mechanism, plus a pathogen-driven autophagy-suppression mechanism, refining ECSIT's context-dependent outputs.","evidence":"Ecsit-X4 AAV9 therapy and cardiomyocyte KO with STAT3 Co-IP and pS727 blot; M. tuberculosis HBHA binding, ECSIT KD, autophagy markers and bacterial survival","pmids":["39746855","41209015"],"confidence":"Medium","gaps":["Functional distinction between ECSIT-X4 and canonical isoform not fully mapped","HBHA-ECSIT interface and selectivity over TRAF6 binding undefined"]},{"year":2026,"claim":"Showed mitochondrial ECSIT can recruit a deubiquitinase to control mitochondrial protein stability and oxidative stress, extending its mitochondrial scaffolding role to metabolic disease.","evidence":"Mitochondria-targeted ECSIT transgenic mice, OTUD3 Co-IP, SIRT3 deubiquitination assay, mtDNA oxidation and MASH models","pmids":["41640247"],"confidence":"Medium","gaps":["Whether ECSIT directly recruits OTUD3 or acts indirectly not resolved","Relationship to complex I assembly function unclear"]},{"year":null,"claim":"How ECSIT's distinct molecular activities — TRAF6/NF-κB scaffolding, complex I assembly, Smad co-factor function, and metabolite-driven epigenetic regulation — are partitioned and coordinated within a single protein remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model unifying the signaling and mitochondrial functions","Mechanism switching ECSIT between cytosolic and mitochondrial pools unknown","E3 ligase and deubiquitinase network controlling ECSIT modification incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,4,6]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[2,9]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,9,18,20]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,4]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,5]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,4,6,9]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[2,9,13]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[9,14,17]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,5]}],"complexes":["TAK1-ECSIT-TRAF6 complex","mitochondrial complex I assembly intermediate (with NDUFAF1)"],"partners":["TRAF6","MEKK-1","TAK1","NDUFAF1","SMAD4","SMAD1","PINK1","STAT3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9BQ95","full_name":"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial","aliases":["Protein SITPEC"],"length_aa":431,"mass_kda":49.1,"function":"Adapter protein that plays a role in different signaling pathways including TLRs and IL-1 pathways or innate antiviral induction signaling. Plays a role in the activation of NF-kappa-B by forming a signal complex with TRAF6 and TAK1/MAP3K7 to activate TAK1/MAP3K7 leading to activation of IKKs (PubMed:25355951, PubMed:31281713). Once ubiquitinated, interacts with the dissociated RELA and NFKB1 proteins and translocates to the nucleus where it induces NF-kappa-B-dependent gene expression (PubMed:25355951). Plays a role in innate antiviral immune response by bridging the pattern recognition receptors RIGI and MDA5/IFIT1 to the MAVS complex at the mitochondrion (PubMed:25228397). Promotes proteolytic activation of MAP3K1. Involved in the BMP signaling pathway. Required for normal embryonic development (By similarity) As part of the MCIA complex, involved in the assembly of the mitochondrial complex I","subcellular_location":"Cytoplasm; Nucleus; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q9BQ95/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ECSIT","classification":"Not Classified","n_dependent_lines":148,"n_total_lines":1208,"dependency_fraction":0.12251655629139073},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ECSIT","total_profiled":1310},"omim":[{"mim_id":"616148","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 59; TRIM59","url":"https://www.omim.org/entry/616148"},{"mim_id":"615533","title":"TRANSMEMBRANE PROTEIN 126B; TMEM126B","url":"https://www.omim.org/entry/615533"},{"mim_id":"611126","title":"MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20; MC1DN20","url":"https://www.omim.org/entry/611126"},{"mim_id":"608388","title":"ECSIT SIGNALING INTEGRATOR; ECSIT","url":"https://www.omim.org/entry/608388"},{"mim_id":"603030","title":"TOLL-LIKE RECEPTOR 4; TLR4","url":"https://www.omim.org/entry/603030"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ECSIT"},"hgnc":{"alias_symbol":["SITPEC"],"prev_symbol":[]},"alphafold":{"accession":"Q9BQ95","domains":[{"cath_id":"-","chopping":"213-250_261-312_354-399","consensus_level":"medium","plddt":88.7502,"start":213,"end":399},{"cath_id":"1.25.40","chopping":"70-209","consensus_level":"high","plddt":87.1247,"start":70,"end":209}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BQ95","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQ95-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BQ95-F1-predicted_aligned_error_v6.png","plddt_mean":71.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ECSIT","jax_strain_url":"https://www.jax.org/strain/search?query=ECSIT"},"sequence":{"accession":"Q9BQ95","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BQ95.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BQ95/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BQ95"}},"corpus_meta":[{"pmid":"10465784","id":"PMC_10465784","title":"ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10465784","citation_count":259,"is_preprint":false},{"pmid":"17344420","id":"PMC_17344420","title":"Cytosolic signaling protein Ecsit also localizes to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17344420","citation_count":160,"is_preprint":false},{"pmid":"25371197","id":"PMC_25371197","title":"TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25371197","citation_count":87,"is_preprint":false},{"pmid":"22588174","id":"PMC_22588174","title":"TRIM59 interacts with ECSIT and negatively regulates NF-κB and IRF-3/7-mediated signal pathways.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22588174","citation_count":82,"is_preprint":false},{"pmid":"14633973","id":"PMC_14633973","title":"Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/14633973","citation_count":78,"is_preprint":false},{"pmid":"29514094","id":"PMC_29514094","title":"An Essential Role for ECSIT in Mitochondrial Complex I Assembly and Mitophagy in Macrophages.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29514094","citation_count":72,"is_preprint":false},{"pmid":"29291352","id":"PMC_29291352","title":"Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma.","date":"2018","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29291352","citation_count":58,"is_preprint":false},{"pmid":"28393051","id":"PMC_28393051","title":"Peroxiredoxin-6 Negatively Regulates Bactericidal Activity and NF-κB Activity by Interrupting TRAF6-ECSIT Complex.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28393051","citation_count":40,"is_preprint":false},{"pmid":"22513506","id":"PMC_22513506","title":"Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction. Hypothetical role of the adapter protein ECSIT in familial and sporadic Alzheimer's disease pathogenesis.","date":"2012","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22513506","citation_count":35,"is_preprint":false},{"pmid":"25355951","id":"PMC_25355951","title":"Ubiquitination of ECSIT is crucial for the activation of p65/p50 NF-κBs in Toll-like receptor 4 signaling.","date":"2014","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/25355951","citation_count":31,"is_preprint":false},{"pmid":"25228397","id":"PMC_25228397","title":"ECSIT bridges RIG-I-like receptors to VISA in signaling events of innate antiviral responses.","date":"2014","source":"Journal of innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25228397","citation_count":27,"is_preprint":false},{"pmid":"29288875","id":"PMC_29288875","title":"ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells.","date":"2017","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/29288875","citation_count":24,"is_preprint":false},{"pmid":"31620128","id":"PMC_31620128","title":"CRBN Is a Negative Regulator of Bactericidal Activity and Autophagy Activation Through Inhibiting the Ubiquitination of ECSIT and BECN1.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31620128","citation_count":24,"is_preprint":false},{"pmid":"12762272","id":"PMC_12762272","title":"Diagnostic pathway of syncope and analysis of the impact of guidelines in a district general hospital. The ECSIT study (epidemiology and costs of syncope in Trento).","date":"2003","source":"Italian heart journal : official journal of the Italian Federation of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/12762272","citation_count":23,"is_preprint":false},{"pmid":"24796866","id":"PMC_24796866","title":"Role of evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) in the antibacterial immunity of Marsupenaeus japonicus.","date":"2014","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24796866","citation_count":18,"is_preprint":false},{"pmid":"31281713","id":"PMC_31281713","title":"p62 Negatively Regulates TLR4 Signaling via Functional Regulation of the TRAF6-ECSIT Complex.","date":"2019","source":"Immune network","url":"https://pubmed.ncbi.nlm.nih.gov/31281713","citation_count":17,"is_preprint":false},{"pmid":"17187402","id":"PMC_17187402","title":"The nexus of iron and inflammation in hepcidin regulation: SMADs, STATs, and ECSIT.","date":"2007","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/17187402","citation_count":17,"is_preprint":false},{"pmid":"34032637","id":"PMC_34032637","title":"ECSIT is a critical limiting factor for cardiac function.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34032637","citation_count":15,"is_preprint":false},{"pmid":"38326554","id":"PMC_38326554","title":"ECSIT facilitates memory CD8+ T cell development by mediating fumarate synthesis during viral infection and tumorigenesis.","date":"2024","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38326554","citation_count":14,"is_preprint":false},{"pmid":"35173723","id":"PMC_35173723","title":"The ECSIT Mediated Toll3-Dorsal-ALFs Pathway Inhibits Bacterial Amplification in Kuruma Shrimp.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35173723","citation_count":14,"is_preprint":false},{"pmid":"37152948","id":"PMC_37152948","title":"ECSIT is essential for RANKL-induced stimulation of mitochondria in osteoclasts and a target for the anti-osteoclastogenic effects of estrogens.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37152948","citation_count":14,"is_preprint":false},{"pmid":"25449573","id":"PMC_25449573","title":"Hepatitis B virus X protein increases the IL-1β-induced NF-κB activation via interaction with evolutionarily conserved signaling intermediate in Toll pathways (ECSIT).","date":"2014","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/25449573","citation_count":14,"is_preprint":false},{"pmid":"37409430","id":"PMC_37409430","title":"ECSIT Is a Critical Factor for Controlling Intestinal Homeostasis and Tumorigenesis through Regulating the Translation of YAP Protein.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37409430","citation_count":11,"is_preprint":false},{"pmid":"26204814","id":"PMC_26204814","title":"Identification and function of an evolutionarily conserved signaling intermediate in Toll pathways (ECSIT) from Crassostrea hongkongensis.","date":"2015","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26204814","citation_count":11,"is_preprint":false},{"pmid":"39488037","id":"PMC_39488037","title":"ECSIT: Biological function and involvement in diseases.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39488037","citation_count":9,"is_preprint":false},{"pmid":"33238179","id":"PMC_33238179","title":"Identification, characterization, and functional analysis of Toll and ECSIT in Exopalaemon carinicauda.","date":"2020","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33238179","citation_count":8,"is_preprint":false},{"pmid":"37395010","id":"PMC_37395010","title":"Tissue-specific differences in the assembly of mitochondrial Complex I are revealed by a novel ENU mutation in ECSIT.","date":"2023","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/37395010","citation_count":8,"is_preprint":false},{"pmid":"36087818","id":"PMC_36087818","title":"Molecular characterization of the evolutionary conserved signaling intermediate in Toll pathways (ECSIT) of soiny mullet (Liza haematocheila).","date":"2022","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36087818","citation_count":7,"is_preprint":false},{"pmid":"39746855","id":"PMC_39746855","title":"ECSIT-X4 is Required for Preventing Pressure Overload-Induced Cardiac Hypertrophy via Regulating Mitochondrial STAT3.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39746855","citation_count":6,"is_preprint":false},{"pmid":"39384444","id":"PMC_39384444","title":"Emerging roles of ECSIT in immunity and tumorigenesis.","date":"2024","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/39384444","citation_count":5,"is_preprint":false},{"pmid":"26909903","id":"PMC_26909903","title":"Characterization, molecular cloning, and expression analysis of Ecsit in the spinyhead croaker, Collichthys lucidus.","date":"2016","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26909903","citation_count":5,"is_preprint":false},{"pmid":"35853181","id":"PMC_35853181","title":"Pleiotropic roles of evolutionarily conserved signaling intermediate in toll pathway (ECSIT) in pathophysiology.","date":"2022","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35853181","citation_count":4,"is_preprint":false},{"pmid":"35571656","id":"PMC_35571656","title":"ECSIT inhibits cell death to increase tumor progression and metastasis via p53 in human breast cancer.","date":"2022","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35571656","citation_count":3,"is_preprint":false},{"pmid":"37531975","id":"PMC_37531975","title":"Large-scale lysine crotonylation analysis reveals the role of TRAF6-Ecsit complex in endoplasmic reticulum stress in mud crab (Scylla paramamosain).","date":"2023","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37531975","citation_count":2,"is_preprint":false},{"pmid":"41209015","id":"PMC_41209015","title":"HBHA-ECSIT interaction disrupts macrophage autophagy to promote Mycobacterium tuberculosis persistence.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41209015","citation_count":1,"is_preprint":false},{"pmid":"28251965","id":"PMC_28251965","title":"[Amphioxus ortholog of ECSIT, an evolutionarily conserved adaptor in the Toll and BMP signaling pathways].","date":"2017","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/28251965","citation_count":1,"is_preprint":false},{"pmid":"41640247","id":"PMC_41640247","title":"Targeted Mitochondrial ECSIT Overexpression Attenuates MASH by Increasing OTUD3 Expression.","date":"2026","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41640247","citation_count":0,"is_preprint":false},{"pmid":"41611204","id":"PMC_41611204","title":"A protective role of ECSIT in chemotherapy-induced intestinal mucositis by maintaining Lgr5+ intestinal stem cells and gut homeostasis.","date":"2026","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41611204","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.19.24314011","title":"Correspondence: Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma","date":"2024-09-22","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.19.24314011","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20562,"output_tokens":5604,"usd":0.072873,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14260,"output_tokens":4782,"usd":0.095425,"stage2_stop_reason":"end_turn"},"total_usd":0.168298,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"ECSIT acts as an adaptor protein bridging TRAF6 to MEKK-1 in the Toll/IL-1 signaling pathway; wild-type ECSIT accelerates MEKK-1 processing while a dominant-negative fragment blocks MEKK-1 processing and NF-κB activation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, dominant-negative overexpression, NF-κB reporter assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction studies plus functional dominant-negative experiments; foundational paper replicated and built upon by multiple subsequent labs\",\n      \"pmids\": [\"10465784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ECSIT is required for BMP signaling during mouse embryogenesis; it associates constitutively with Smad4 and associates with Smad1 in a BMP-inducible manner, and together with Smad1/Smad4 binds promoters of specific BMP target genes. Ecsit null mice show impaired mesoderm formation and embryonic lethality at E7.5.\",\n      \"method\": \"Targeted gene knockout (null mutation), co-immunoprecipitation, chromatin immunoprecipitation, shRNA knockdown, reporter assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo knockout with defined phenotype, reciprocal Co-IP, ChIP, and functional rescue experiments in single rigorous study\",\n      \"pmids\": [\"14633973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"ECSIT localizes to mitochondria via an N-terminal targeting signal, where it interacts with the assembly chaperone NDUFAF1 in 500–850 kDa complexes; RNAi knockdown of either ECSIT or NDUFAF1 severely impairs mitochondrial complex I assembly and function.\",\n      \"method\": \"Affinity purification, subcellular fractionation, RNAi knockdown, blue native PAGE, mitochondrial function assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal affinity purification, bidirectional RNAi, biochemical fractionation demonstrating mitochondrial localization with functional consequence; replicated in multiple subsequent studies\",\n      \"pmids\": [\"17344420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRIM59 interacts with ECSIT (co-immunoprecipitation) and acts as a negative regulator of NF-κB and IRF-3/7-mediated signaling; overexpression of TRIM59 represses NF-κB, IFN-β promoter, and ISRE transcriptional activities, while TRIM59 knockdown enhances them. TRIM59 also inhibits phosphorylation and dimerization of IRF3 and IRF7.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assays, siRNA knockdown, Western blot (phosphorylation)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single Co-IP plus functional reporter assays and phosphorylation analysis; single lab\",\n      \"pmids\": [\"22588174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Upon LPS stimulation, ECSIT forms a trimeric complex with TAK1 and TRAF6; ECSIT interacts with each protein and regulates TAK1 activity to activate NF-κB. ECSIT mutants lacking the TAK1- or TRAF6-interacting domain cannot restore NF-κB activity or cytokine production in ECSIT-knockdown cells.\",\n      \"method\": \"Co-immunoprecipitation of endogenous proteins, ECSIT-knockdown (THP-1), domain-deletion mutant rescue, NF-κB reporter assay, cytokine ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — endogenous complex IP, domain-mapping mutagenesis, knockdown rescue, and multiple functional readouts; single lab with orthogonal methods\",\n      \"pmids\": [\"25371197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ECSIT ubiquitination at lysine 372 is required for its interaction with p65/p50 NF-κB proteins and their nuclear co-localization following TLR4 stimulation; the K372A mutant fails to interact with NF-κB subunits and cannot restore NF-κB DNA-binding activity or cytokine production in ECSIT-knockdown cells.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (K372A), subcellular fractionation, NF-κB EMSA/reporter assays, cytokine measurement, ECSIT-knockdown rescue\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — active-site (ubiquitination site) mutagenesis with functional validation, knockdown rescue, multiple orthogonal assays; single lab\",\n      \"pmids\": [\"25355951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ECSIT serves as an essential scaffolding protein that bridges RIG-I and MDA5 to VISA (MAVS) on mitochondria, mediating virus-triggered type I IFN induction; ECSIT overexpression potentiates IRF3 activation and IFNB1 expression, while ECSIT knockdown impairs these antiviral responses.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, overexpression, IRF3 activation assay, IFNB1 reporter/expression assay\",\n      \"journal\": \"Journal of innate immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP of ECSIT with VISA/RIG-I/MDA5, bidirectional functional perturbation (OE and KD); single lab\",\n      \"pmids\": [\"25228397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Hepatitis B virus X protein (HBx) physically interacts with ECSIT (GST pulldown and co-IP); the interacting region of HBx maps to amino acids 51–80; the HBx–ECSIT interaction augments IL-1β-induced NF-κB activation by increasing IKK and IκBα phosphorylation and promoting p65/p50 nuclear translocation.\",\n      \"method\": \"GST pulldown, co-immunoprecipitation, CytoTrap two-hybrid, deletion analysis, NF-κB reporter assay, Western blot (phosphorylation)\",\n      \"journal\": \"Virus research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — GST pulldown plus co-IP with domain mapping and functional signaling assays; single lab\",\n      \"pmids\": [\"25449573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Peroxiredoxin-6 (Prdx6) competitively interacts with ECSIT at the TRAF-C domain of TRAF6, disrupting the TRAF6–ECSIT complex; this inhibits ECSIT ubiquitination, reduces mitochondrial ROS production, and suppresses TLR4-induced NF-κB activation and bactericidal activity.\",\n      \"method\": \"Co-immunoprecipitation, Prdx6 knockdown, competitive binding assay, mitochondrial ROS measurement, NF-κB reporter, cytokine assay, bacterial survival assay\",\n      \"journal\": \"Frontiers in cellular and infection microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — competitive Co-IP with domain mapping, bidirectional perturbation (OE and KD), multiple functional readouts; single lab\",\n      \"pmids\": [\"28393051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Conditional knockout of ECSIT in macrophages completely disrupts complex I activity and the CI holoenzyme, causes a metabolic shift to glycolysis, increases constitutive mitochondrial ROS, and impairs mitophagy. ECSIT associates with the mitophagy regulator PINK1 and undergoes Parkin-dependent ubiquitination; ECSIT deletion increases mitochondrial Parkin without restoring mitophagy.\",\n      \"method\": \"Conditional knockout mouse (Cre-lox), complex I activity assay, blue native PAGE, metabolic flux (Seahorse), mROS measurement, co-immunoprecipitation (PINK1), ubiquitination assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with detailed mechanistic dissection, multiple orthogonal assays (biochemical, metabolic, mitophagy), Co-IP of PINK1 interaction; single lab but highly rigorous\",\n      \"pmids\": [\"29514094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The ECSIT V140A mutation increases ECSIT affinity for the S100A8/S100A9 heterodimer, potentiating NF-κB activation and NADPH oxidase activity. ECSIT-T419C knock-in mice showed higher peritoneal NADPH oxidase activity than wild-type in response to LPS. ECSIT-V140A-expressing ENKTL cells produced TNF-α and IFN-γ that induced macrophage activation and cytokine secretion.\",\n      \"method\": \"Exome sequencing, knock-in mouse model, co-immunoprecipitation, NADPH oxidase activity assay, NF-κB reporter, cytokine measurement, xenograft model\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knock-in mouse, biochemical interaction studies, functional assays in cells and in vivo; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"29291352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRBN (cereblon) translocates to mitochondria upon TLR4 stimulation and disrupts the ECSIT–TRAF6 complex, thereby inhibiting TRAF6-induced ubiquitination of ECSIT and suppressing mitochondrial ROS production and bactericidal activity.\",\n      \"method\": \"Co-immunoprecipitation, CRBN knockdown/knockout, mitochondrial fractionation, mROS measurement, bacterial survival assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP showing competitive disruption, bidirectional perturbation, functional mROS and bactericidal readouts; single lab\",\n      \"pmids\": [\"31620128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"p62 (SQSTM1) interacts with the internal domain of ECSIT, inhibits TRAF6–ECSIT association, and attenuates ECSIT ubiquitination, thereby suppressing TLR4-mediated NF-κB activation; p62-knockout MEF cells and mice show markedly enhanced TLR4 signaling and inflammatory responses.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, p62 knockout MEF cells, p62 knockout mice, NF-κB reporter, cytokine measurement, ubiquitination assay\",\n      \"journal\": \"Immune network\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP with domain mapping, p62-KO cells and mice with functional signaling readouts; single lab\",\n      \"pmids\": [\"31281713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human ECSIT (hECSIT) is highly labile compared to murine Ecsit; low hECSIT levels lead to reduced complex I assembly and activity, impaired oxidative phosphorylation, reduced ATP production, altered mitochondrial dynamics (reduced fusion, increased fission), and severe cardiac hypertrophy in humanized knock-in mice. ECSIT also has a cardiomyocyte-intrinsic role in mitochondrial function.\",\n      \"method\": \"Humanized knock-in mouse (mEcsit replaced by hECSIT), complex I activity/assembly assay, Seahorse metabolic flux, mitochondrial morphology imaging, cardiac function assays\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic knock-in mouse with multiple orthogonal biochemical, metabolic, and in vivo cardiac readouts; single lab but rigorous\",\n      \"pmids\": [\"34032637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RANKL promotes ECSIT–TRAF6 interaction and increases mitochondrial ECSIT levels in osteoclast progenitors; ECSIT silencing decreases complex I activity, oxygen consumption, NAD+/NADH ratio, ATP production, and increases mitochondrial ROS, abrogating RANKL-driven stimulation of oxidative phosphorylation and osteoclastogenesis. 17β-estradiol (E2) abrogates these RANKL-induced effects on ECSIT.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, shRNA knockdown, Seahorse XF metabolic analysis, complex I activity assay, ROS measurement, mitochondrial membrane potential assay\",\n      \"journal\": \"Frontiers in endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, fractionation, shRNA KD with multiple orthogonal metabolic and functional assays; single lab but comprehensive methodology\",\n      \"pmids\": [\"37152948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ECSIT-N209I ENU-induced mutation causes tissue-specific complex I assembly defects specifically in cardiac tissue, leading to hypertrophic cardiomyopathy without affecting complex I in other tissues, demonstrating tissue-specific requirements for ECSIT in complex I assembly.\",\n      \"method\": \"ENU mutagenesis screen, Seahorse extracellular flux, biochemical complex I assays, blue native PAGE, cardiac phenotyping\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo point mutation with tissue-specific biochemical and functional validation; single lab\",\n      \"pmids\": [\"37395010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Intestinal cell-specific ablation of ECSIT causes metabolic reprogramming toward amino acid-based metabolism, demethylation and upregulation of eIF4F pathway genes, and consequently enhanced YAP protein translation (not transcription), disrupting intestinal differentiation and promoting tumorigenesis.\",\n      \"method\": \"Intestinal epithelium-specific conditional knockout, proteomics, metabolomics, ribosome profiling/translation assays, Western blot, reporter assays\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific KO with multi-omics and mechanistic follow-up on translation pathway; single lab\",\n      \"pmids\": [\"37409430\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ECSIT mediates fumarate synthesis in CD8+ T cells; T cell-specific ECSIT ablation abolishes fumarate production and abrogates TCF-1 expression via KDM5-mediated demethylation of the TCF-1 promoter, impairing memory CD8+ T cell differentiation in a cell-intrinsic manner.\",\n      \"method\": \"T cell-specific conditional knockout, metabolomics (fumarate measurement), ChIP/methylation analysis, KDM5 inhibition, adoptive transfer experiments\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with metabolomics, epigenetic mechanism (ChIP, methylation), cell-intrinsic adoptive transfer; single lab but multiple orthogonal methods in rigorous study\",\n      \"pmids\": [\"38326554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A novel 42-kDa ECSIT isoform encoded by transcript variant Ecsit-X4 localizes to mitochondria of adult cardiomyocytes; it interacts with STAT3 and increases mitochondrial STAT3 levels and serine 727 phosphorylation, thereby promoting mitochondrial bioenergetics and protecting against pressure overload-induced cardiac hypertrophy.\",\n      \"method\": \"AAV9-mediated gene therapy, cardiomyocyte-specific Ecsit conditional knockout, co-immunoprecipitation (STAT3 interaction), Western blot (phospho-STAT3-S727), mitochondrial fractionation, Seahorse metabolic analysis, TAC surgical model\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO rescue and AAV gene therapy with Co-IP and phosphorylation analysis; single lab but multiple in vivo and biochemical methods\",\n      \"pmids\": [\"39746855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Mycobacterium tuberculosis virulence factor HBHA directly binds ECSIT, disrupts the ECSIT–TRAF6 complex, and inhibits ECSIT ubiquitination in macrophages, thereby suppressing autophagy (LC3-II conversion and Beclin-1 expression unchanged in ECSIT-knockdown cells upon HBHA treatment) and promoting intracellular mycobacterial survival.\",\n      \"method\": \"Co-immunoprecipitation, ECSIT knockdown (RAW264.7), ubiquitination assay, LC3-II/Beclin-1 Western blot, intracellular bacterial survival assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP, genetic ablation with mechanistic readouts (ubiquitination, autophagy markers, bacterial survival); single lab\",\n      \"pmids\": [\"41209015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"Mitochondria-targeted ECSIT overexpression promotes localization of deubiquitinase OTUD3 to mitochondria; OTUD3 then stabilizes SIRT3 via deubiquitination, inhibiting mtDNA oxidation and alleviating diet-induced MASH phenotypes.\",\n      \"method\": \"Mitochondria-targeted transgenic mice (ECSITMTG), co-immunoprecipitation, deubiquitination assay, mitochondrial fractionation, mtDNA oxidation measurement, dietary MASH models\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic mouse model with Co-IP, deubiquitination biochemistry, and functional metabolic readouts; single lab\",\n      \"pmids\": [\"41640247\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ECSIT is a multifunctional adaptor protein that operates in at least three major mechanistic contexts: (1) in innate immune/TLR signaling, it bridges TRAF6 to MEKK-1 to promote NF-κB activation, forms a TAK1-ECSIT-TRAF6 trimeric complex, scaffolds RIG-I/MDA5 to MAVS for antiviral IFN induction, and its ubiquitination at K372 is required for NF-κB p65/p50 nuclear interaction; (2) in mitochondria (directed by an N-terminal targeting sequence), it interacts with NDUFAF1 and is essential for mitochondrial complex I assembly and activity, regulates mitochondrial ROS production that facilitates bacterial clearance, associates with PINK1 and undergoes Parkin-dependent ubiquitination to regulate mitophagy, and a cardiomyocyte-specific isoform (ECSIT-X4) interacts with STAT3 to sustain mitochondrial bioenergetics; and (3) in development and differentiation, it co-operates with Smad1/Smad4 as a BMP pathway co-factor for mesoderm formation, and in CD8+ T cells it mediates fumarate synthesis that suppresses KDM5-dependent TCF-1 promoter demethylation to support memory T cell development.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ECSIT is a multifunctional adaptor protein that couples innate immune signaling to mitochondrial function, operating both as a scaffold in Toll/IL-1 receptor pathways and as an essential factor for respiratory complex I assembly [#0, #2]. In TLR/IL-1 signaling it bridges TRAF6 to MEKK-1 to drive NF-\\u03baB activation [#0], assembles a TAK1\\u2013ECSIT\\u2013TRAF6 trimeric complex through distinct interaction domains required for cytokine production [#4], and scaffolds RIG-I and MDA5 onto MAVS to induce type I interferon during antiviral responses [#6]. ECSIT ubiquitination at lysine 372 is required for its interaction with NF-\\u03baB p65/p50 and their nuclear function following TLR4 stimulation [#5], and the integrity of the TRAF6\\u2013ECSIT complex \\u2014 controlled by competitive binders including Prdx6, CRBN, p62/SQSTM1, and the pathogen factors HBx and HBHA \\u2014 governs ECSIT ubiquitination, mitochondrial ROS production, and bactericidal/autophagic activity [#8, #11, #12, #19]. Independently, ECSIT localizes to mitochondria via an N-terminal targeting signal where it partners with the assembly chaperone NDUFAF1 and is indispensable for complex I assembly and oxidative phosphorylation [#2, #9]; loss of ECSIT collapses complex I, shifts metabolism toward glycolysis, raises constitutive mitochondrial ROS, and impairs mitophagy, with ECSIT associating with PINK1 and undergoing Parkin-dependent ubiquitination [#9]. This mitochondrial role underlies tissue-specific physiology: human ECSIT lability or point mutations cause cardiac complex I deficiency and hypertrophy [#13, #15], a cardiomyocyte ECSIT-X4 isoform sustains bioenergetics through mitochondrial STAT3 [#18], and ECSIT supports RANKL-driven osteoclast metabolism [#14]. ECSIT also acts at the chromatin/metabolite interface, cooperating with Smad1/Smad4 as a BMP co-factor essential for mesoderm formation [#1] and, in CD8+ T cells, driving fumarate synthesis that suppresses KDM5-dependent demethylation of the TCF-1 promoter to support memory differentiation [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established ECSIT's founding role as a signaling adaptor, answering how TRAF6 connects to downstream MAP3K activity in Toll/IL-1 signaling.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, and dominant-negative NF-\\u03baB reporter assays identifying ECSIT as a TRAF6\\u2013MEKK-1 bridge\",\n      \"pmids\": [\"10465784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether MEKK-1 processing is direct or requires additional factors\", \"No structural basis for the bridging interaction\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Revealed an unexpected developmental function, showing ECSIT acts as a BMP/Smad transcriptional co-factor required for embryonic mesoderm formation.\",\n      \"evidence\": \"Ecsit-null mice (embryonic lethal E7.5), Smad1/Smad4 Co-IP, ChIP at BMP target promoters, shRNA and reporter assays\",\n      \"pmids\": [\"14633973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between ECSIT's TLR-adaptor and Smad co-factor roles unresolved\", \"Direct DNA-binding vs. recruitment by Smads not distinguished\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified a distinct mitochondrial function, answering where ECSIT localizes and revealing it is essential for respiratory complex I assembly.\",\n      \"evidence\": \"Affinity purification with NDUFAF1, subcellular fractionation, bidirectional RNAi, blue native PAGE\",\n      \"pmids\": [\"17344420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single protein partitions between signaling and mitochondrial pools not defined\", \"Biochemical role within the assembly intermediate not specified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Dissected the architecture and ubiquitination requirements of ECSIT in TLR signaling, establishing the trimeric TAK1\\u2013ECSIT\\u2013TRAF6 complex and a K372 ubiquitination switch for NF-\\u03baB engagement.\",\n      \"evidence\": \"Endogenous Co-IP, domain-deletion and K372A mutant rescue in knockdown cells, EMSA, cytokine readouts\",\n      \"pmids\": [\"25371197\", \"25355951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the K372 E3 ligase not established\", \"Whether ubiquitination is mono- or poly- and its chain type undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended ECSIT's immune scaffolding to antiviral sensing and identified viral and host regulators, showing it bridges RIG-I/MDA5 to MAVS and is targeted by HBx and TRIM59.\",\n      \"evidence\": \"Co-IP, siRNA/overexpression IRF3 and IFNB1 assays; GST pulldown and reporter assays for HBx and TRIM59\",\n      \"pmids\": [\"25228397\", \"25449573\", \"22588174\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RIG-I/MDA5-MAVS bridging shown by Co-IP without reciprocal structural validation\", \"Host vs. viral regulation hierarchy unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked ECSIT's mitochondrial role to immune effector output and mitophagy, showing complex I loss reprograms metabolism, elevates ROS, and disrupts PINK1/Parkin-dependent mitophagy.\",\n      \"evidence\": \"Macrophage conditional knockout, complex I assays, Seahorse, PINK1 Co-IP, Parkin-dependent ubiquitination assay; ENKTL ECSIT-V140A knock-in mouse and S100A8/A9 binding\",\n      \"pmids\": [\"29514094\", \"29291352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ECSIT integrates into mitophagy beyond PINK1 association not defined\", \"Mechanism of V140A gain-of-function affinity change not structurally explained\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the TRAF6\\u2013ECSIT complex as a regulatory node, showing competitive binders (CRBN, p62) and the requirement of ECSIT ubiquitination for mitochondrial ROS and bactericidal activity.\",\n      \"evidence\": \"Co-IP/domain mapping, p62-KO cells and mice, CRBN knockdown, mROS and bacterial survival assays\",\n      \"pmids\": [\"31620128\", \"31281713\", \"28393051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether competitive disruptors act at the same TRAF-C interface for all is not unified\", \"Quantitative contribution of each regulator in vivo unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated species- and tissue-specific physiological consequences of ECSIT abundance, with human ECSIT lability causing complex I deficiency and cardiac hypertrophy.\",\n      \"evidence\": \"Humanized hECSIT knock-in mice, complex I assembly/activity assays, Seahorse, mitochondrial morphology imaging, cardiac phenotyping\",\n      \"pmids\": [\"34032637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of human ECSIT instability not defined\", \"Cardiomyocyte-intrinsic vs. systemic contributions only partly separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Generalized ECSIT's metabolic-gatekeeper role across osteoclasts, cardiac tissue, and intestine, including a translation-control mechanism affecting YAP.\",\n      \"evidence\": \"RANKL osteoclast Co-IP and Seahorse; ENU ECSIT-N209I cardiac mutant; intestinal conditional KO with proteomics, metabolomics, and ribosome profiling\",\n      \"pmids\": [\"37152948\", \"37395010\", \"37409430\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking complex I loss to eIF4F demethylation and YAP translation incompletely defined\", \"Tissue specificity of complex I requirement mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected ECSIT-dependent mitochondrial metabolism to epigenetic control of cell fate, showing ECSIT-driven fumarate suppresses KDM5 demethylation of the TCF-1 promoter for memory CD8+ T cell formation.\",\n      \"evidence\": \"T cell-specific conditional KO, fumarate metabolomics, ChIP/methylation, KDM5 inhibition, adoptive transfer\",\n      \"pmids\": [\"38326554\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ECSIT enzymatically/structurally controls fumarate flux not detailed\", \"Generality of the fumarate-KDM5 axis to other cell types unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified an isoform-specific and STAT3-dependent cardioprotective mechanism, plus a pathogen-driven autophagy-suppression mechanism, refining ECSIT's context-dependent outputs.\",\n      \"evidence\": \"Ecsit-X4 AAV9 therapy and cardiomyocyte KO with STAT3 Co-IP and pS727 blot; M. tuberculosis HBHA binding, ECSIT KD, autophagy markers and bacterial survival\",\n      \"pmids\": [\"39746855\", \"41209015\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional distinction between ECSIT-X4 and canonical isoform not fully mapped\", \"HBHA-ECSIT interface and selectivity over TRAF6 binding undefined\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Showed mitochondrial ECSIT can recruit a deubiquitinase to control mitochondrial protein stability and oxidative stress, extending its mitochondrial scaffolding role to metabolic disease.\",\n      \"evidence\": \"Mitochondria-targeted ECSIT transgenic mice, OTUD3 Co-IP, SIRT3 deubiquitination assay, mtDNA oxidation and MASH models\",\n      \"pmids\": [\"41640247\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether ECSIT directly recruits OTUD3 or acts indirectly not resolved\", \"Relationship to complex I assembly function unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How ECSIT's distinct molecular activities \\u2014 TRAF6/NF-\\u03baB scaffolding, complex I assembly, Smad co-factor function, and metabolite-driven epigenetic regulation \\u2014 are partitioned and coordinated within a single protein remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model unifying the signaling and mitochondrial functions\", \"Mechanism switching ECSIT between cytosolic and mitochondrial pools unknown\", \"E3 ligase and deubiquitinase network controlling ECSIT modification incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 4, 6]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [2, 9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 9, 18, 20]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 4, 6, 9]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [2, 9, 13]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [9, 14, 17]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 5]}\n    ],\n    \"complexes\": [\n      \"TAK1-ECSIT-TRAF6 complex\",\n      \"mitochondrial complex I assembly intermediate (with NDUFAF1)\"\n    ],\n    \"partners\": [\n      \"TRAF6\",\n      \"MEKK-1\",\n      \"TAK1\",\n      \"NDUFAF1\",\n      \"Smad4\",\n      \"Smad1\",\n      \"PINK1\",\n      \"STAT3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}